Process for typing of HCV isolates

• US 7,258,977 B1
• Filed: 04/14/2003
• Issued: 08/21/2007
• Est. Priority Date: 11/27/1992
• Status: Expired due to Fees

• Current Assignee: Innogenetics NV (H.U. Group Holdings, Inc.)
• Original Assignee: Innogenetics NV (H.U. Group Holdings, Inc.)
• Inventors: Maertens, Geert, Stuyver, Lieven, Rossau, Rudi, Van Heuverswyn, Hugo
• Primary Examiner(s): WHISENANT, ETHAN C
• Application Number:
  US10/412,290
• Time in Patent Office: 1,590 Days
• Field of Search: 435/6, 536/23.1, 536/24.3
• US Class Current: 435/5
• CPC Class Codes: C12Q 1/707 non-A, non-B Hepatitis, excluding hepatitis D

Abstract

The invention relates to a process for genotyping any HCV isolate present in a biological sample, previously identified as being HCV positive, and for classifying said isolate according to the percentage of homology with other HCV isolates, comprising the steps of:

• • contacting said sample in which the ribonucleotides or deoxyribonucleotides have been made accessible, if need be, under suitable denaturation, with at least one probe from about 10 to about 40 nucleotides, with said probe being liable to hybridize to a region being in the domain extending from nucleotide at position -291 to nucleotide at position -66 of the 5′ untranslated region of one of the HCV isolates represented by their cDNA sequences, with said numbering of position beginning with the first ATG codon of the open reading frame encoding the HCV polyprotein, or with said probe being complementary to the above-defined probes,
  • detecting the complexes possibly formed between said probe and the nucleotide sequence of the HCV isolate to be identified.

Claims

1. A collection of polynucleic acid probes which can be used for genotyping at least three different genotypes of HCV, wherein each probe in said collection hybridizes to the 5′

untranslated region of HCV.

2. A collection of probes according to claim 1 which can be used for genotyping at least four genotypes of HCV.

3. A collection of probes according to claim 1 which can be used for genotyping at least five genotypes of HCV.

4. A collection of probes according to claim 1 which can be used for genotyping at least six genotypes of HCV.

5. A collection of probes according to any of claims 1–

4, wherein said collection is also capable of sub-typing at least four sub-types of HCV.

6. A collection of probes according to any of claims 1–

4, wherein said collection is also capable of sub-typing at least eight sub-types of HCV.

7. A collection of probes according to any of claims 1–

4, wherein said collection is also capable of sub-typing at least twelve sub-types of HCV.

8. A collection of probes according to any of claims 1–

4, wherein said collection is also capable of sub-typing at least sixteen sub-types of HCV.

9. A collection of probes according to any of claims 1–

4, wherein the collection comprises at least two probes that specifically hybridize with at least one pair of domains selected from the group of domain pairs consisting of;

one domain extending from nucleotide at position -170 to nucleotide at position -155 and the other domain extending from nucleotide at position -141 to nucleotide at position -117,

one domain extending from nucleotide at position -170 to nucleotide at position -155 and the other domain extending from nucleotide position -103 to nucleotide at position -88,

one domain extending from nucleotide at position -141 to nucleotide at position -117 and the other domain extending from nucleotide position at -103 to nucleotide at position -88,

one domain extending from nucleotide at position -170 to nucleotide at position -155 and the other domain extending from nucleotide position at -83 to nucleotide at position -68,

one domain extending from nucleotide at position -141 to nucleotide at position -117 and the other domain extending from nucleotide position at -83 to nucleotide at position -68,

one domain extending from nucleotide at position -170 to nucleotide at position -155 and the other domain extending from nucleotide position at -146 to nucleotide at position -130,

one domain extending from nucleotide at position -146 to nucleotide at position -130 and the other domain extending from nucleotide position at -132 to nucleotide at position -117, and

one domain extending from nucleotide at position -146 to nucleotide at position -130 and the other domain extending from nucleotide position at -103 to nucleotide at position -88,

wherein said negative numbering of the nucleotide positions starts at the nucleotide preceding the first ATG codon of the open reading frame encoding the HCV polyprotein.

10. A collection of probes according to claim 9, wherein the collection comprises at least two sets of probes, each set comprising at least two probes, and wherein each set of probes specifically hybridizes with a different pair of domains selected from the recited groups of domain pairs.

11. A collection of probes according to claim 9, wherein the collection comprises at least three sets of probes, each set comprising at least two probes, and wherein each set of probes specifically hybridizes with a different pair of domains selected from the recited groups of domain pairs.

12. A collection of probes according to claim 9, wherein the collection comprises at least four sets of probes, each set comprising at least two probes, and wherein each set of probes specifically hybridizes with a different pair of domains selected from the recited groups of domain pairs.

13. A collection of probes according to any of claims 1–

4, wherein at least two of said probes specifically hybridize to the domain extending from the nucleotides at positions -291 to -66 of the 5′

untranslated region of HCV.

14. A collection of probes according to any of claims 1–

4, wherein at least one of said probes specifically hybridizes to at least 5 contiguous nucleotides in a domain selected from the group consisting of;

(a) the one extending from nucleotide at position -293 to nucleotide at position -278,

(b) the one extending from nucleotide at position -275 to nucleotide at position -260,

(c) the one extending from nucleotide at position -253 to nucleotide at position -238,

(d) the one extending from nucleotide at position -244 to nucleotide at position -229,

(e) the one extending from nucleotide at position -238 to nucleotide at position -223,

(f) the one extending from nucleotide at position -170 to nucleotide at position -155,

(g) the one extending from nucleotide at position -141 to nucleotide at position -117,

(h) the one extending from nucleotide at position -83 to nucleotide at position -68,

(i) the one extending from nucleotide at position -103 to nucleotide at position -88, and

(j) the one extending from nucleotide at position -146 to nucleotide at position -130.

15. A collection of probes according to claim 14, wherein said collection comprises at least two probes, each of which specifically hybridizes to at least 5 contiguous nucleotides in a domain selected from the recited group of domains, and wherein the two probes specifically hybridize to different domains selected from the recited group of domains.

16. A collection of probes according to claim 15, wherein said collection comprises at least three probes, each of which specifically hybridizes to at least 5 contiguous nucleotides in a domain selected from the recited group of domains, and wherein the three probes specifically hybridize to different domains selected from the recited group of domains.

17. A collection of probes according to claim 16, wherein said collection comprises at least four probes, each of which specifically hybridizes to at least 5 contiguous nucleotides in a domain selected from the recited group of domains, and wherein the four probes specifically hybridize to different domains selected from the recited group of domains.

18. A collection of probes according to claim 17, wherein said collection comprises at least five probes, each of which specifically hybridizes to at least 5 contiguous nucleotides in a domain selected from the recited group of domains, and wherein the five probes specifically hybridize to different domains selected from the recited group of domains.

19. A collection of probes according to claim 18, wherein said collection comprises at least six probes, each of which specifically hybridizes to at least 5 contiguous nucleotides in a domain selected from the recited group of domains, and wherein the six probes specifically hybridize to different domains selected from the recited group of domains.

20. A collection of probes according to any of claims 1–

4, wherein said collection is capable of genotyping HCV genotypes selected from the group consisting of HCV type 1, HCV type 2, HCV type 3, HCV type 4, HCV type 5, and HCV type 6.

21. A collection of probes according to any of claims 1–

4, wherein at least one probe hybridizes to at least one of the domains selected from the group consisting of

for HCV type 1 and 6;

AAT TGC CAG GAC GAC C (SEQ ID NO;

     5), TCT CCA GGC ATT GAG C (SEQ ID NO;

     6), ATT TGC CAG GAY GAC C (SEQ ID NO;

     28),

for HCV type 1;

GCT CAG TGC CTG GAG A (SEQ ID NO;

     29),

for HCV type 2;

TAG CGT TGG GTT GCG A (SEQ ID NO;

     8), TTR CCG GRA AGA CTG G (SEQ ID NO;

     9), TGR CCG GGC ATA GAG T (SEQ ID NO;

     10), TTA CCG GGA AGA CTG G (SEQ ID NO;

     11), TGA CCG GAC ATA GAG T (SEQ ID NO;

     12), CGT ACA GCC TCC AGG C (SEQ ID NO;

     32), CCG GGA AGA CTG GGT C (SEQ ID NO;

     22), CCG GAA AGA CTG GGT C (SEQ ID NO;

     23), ACC CAC TCT ATG CCC G (SEQ ID NO;

     24), ACC CAC TCT ATG TCC G (SEQ ID NO;

     25), ATA GAG TGG GTT TAT C (SEQ ID NO;

     26), GGA CCC AGT CTT CTT G (SEQ ID NO;

     33), TGC CTG GTC ATT TGG G (SEQ ID NO;

     34),

for HCV type 3;

AAT CGC TGG GGT GAC C (SEQ ID NO;

     13), TTT CTG GGT ATT GAG C (SEQ ID NO;

     14), CCG CGA GAT CAC TAG C (SEQ ID NO;

     21), CCG CAA GAT CAC TAG C (SEQ ID NO;

     36), GAA TCG CCG GGT TGA C (SEQ ID NO;

     54),

for HCV type 4 and 5;

AAT YGC CGG GAT GAC C (SEQ ID NO;

     17),

for HCV type 4;

TTC TTG GAA CTA ACC C (SEQ ID NO;

     18),

for HCV type 4, 3c &

3b;

TTT CCG GGC ATT GAG C (SEQ ID NO;

     19),

for HCV type 4 and 3b;

ATT CGC CGG GAT GAC C (SEQ ID NO;

     38),

for HCV type 4;

GAG TGT TGT ACA GCC T (SEQ ID NO;

     37), GAG TGT TGT GCA GCC T (SEQ ID NO;

     39), AAT CGC CGG GAC GAC C (SEQ ID NO;

     40), AAT GCC CGG CAA TTT G (SEQ ID NO;

     41), AAT CGC CGA GAT GAC C (SEQ ID NO;

     42), AAT GCT CGG AAA TTT G (SEQ ID NO;

     43), AAT CGC CAG GAT GAC C (SEQ ID NO;

     49), TGC CTG GAA ATT TGG G (SEQ ID NO;

     50), GGA ATC GCC AGG ACG A (SEQ ID NO;

     53),

for HCV type 5;

AAT TGC CGG GAT GAC C (SEQ ID NO;

     45), AAT TGC CGG GAC GAC C (SEQ ID NO;

     47), TCT CCG GGC ATT GAG C (SEQ ID NO;

     46), GAG TGT CGA ACA GCC T (SEQ ID NO;

     44),

for HCV type 6;

GGG TCC TTT CCA TTG G (SEQ ID NO;

     48), and

domains fully complementary to all of the above sequences, wherein Y is C or T, and K is G or T, and wherein T is replaced by U.

22. A collection of probes according to claim 21, wherein at least two probes hybridize to domains selected from the recited group, and wherein the at least two probes hybridize to different domains.

23. A collection of probes according to claim 22, wherein at least three probes hybridize to domains selected from the recited group, and wherein the at least three probes hybridize to different domains.

24. A collection of probes according to claim 23, wherein at least four probes hybridize to domains selected from the recited group, and wherein the at least four probes hybridize to different domains.

25. A collection of probes according to any of claims 1–

4, wherein said collection comprises at least one probe which can be used for detecting the presence of HCV type 6.

26. A collection of probes according to claim 25, wherein said at least one probe hybridizes to the domain of:

GGG TCC TTT CCA TTG G (SEQ ID NO;

48)

or a domain fully complementary to the above sequence.

27. A collection of probes according to any of claims 1–

4, wherein said collection comprises a mixture of two or more probes.

28. A collection of probes according to claim 27, wherein said collection comprises a mixture of three or more probes.

29. A kit for genotyping HCV comprising a collection of probes according to any of claims 1–

4.

30. A kit for genotyping HCV according to claim 29, wherein said collection comprises a mixture or two or more probes.

31. A kit for genotyping HCV according to claim 29, wherein said collection comprises a mixture or three or more probes.

32. A kit for genotyping HCV according to claim 29, wherein the collection of probes is immobilized to a solid support.

33. A kit for genotyping HCV according to claim 30, wherein the collection of probes is immobilized to a solid support.

34. A kit for genotyping HCV according to claim 31, wherein the collection of probes is immobilized to a solid support.

37. A collection of probes according to claim 23 wherein said probes have a length of about 5 to 50 nucleotides.

38. A collection of probes according to claim 27 wherein said probes have a length of about 5 to 50 nucleotides.

39. A collection of probes according to claim 28 wherein said probes have a length of about 5 to 50 nucleotides.

40. A collection of probes according to claim 23 wherein said probes have a length of about 10 to about 40 nucleotides.

41. A collection of probes according to claim 27 wherein said probes have a length of about 10 to about 40 nucleotides.

42. A collection of probes according to claim 28 wherein said probes have a length of about 10 to about 40 nucleotides.

43. A collection of probes according to claim 23 wherein said probes have a length of about 15 to about 30 nucleotides.

44. A collection of probes according to claim 27 wherein said probes have a length of about 15 to about 30 nucleotides.

45. A collection of probes according to claim 28 wherein said probes have a length of about 15 to about 30 nucleotides.

35. A probe which specifically hybridizes to a HCV type 6.

36. A probe according to claim 35 which specifically hybridizes to the domain of:

GGG TCC TTT CCA TTG G (SEQ ID NO;

48)

or a domain fully complementary to the above sequence.